You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

T-cell vaccination

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Trial in Johannesburg (AAHI-SC2 Vaccine, AAHI-SC3 Vaccine, EUA or approved vaccine)

Recruiting
  • COVID-19
  • AAHI-SC2 Vaccine
  • +2 more
  • Johannesburg, South Africa
    Wits Vida
Jan 4, 2023

Coronavirus, SARS-CoV-2 Infection, COVID-19 Trial in Imus, Makati City (PepGNP-COVID19 (One vaccination), Water for injection

Not yet recruiting
  • Coronavirus
  • +2 more
  • PepGNP-COVID19 (One vaccination)
  • +3 more
  • Imus, Cavite, Philippines
  • +1 more
Nov 30, 2022

Prostate Specific Antigens, Prostate Tumors Trial run by the National Cancer Institute (NCI) (TARP peptide vaccine, TARP

Completed
Has Results
  • Prostate Specific Antigens
  • Prostate Neoplasms
  • T-cell receptor alternate reading frame protein (TARP) peptide vaccine
  • T-cell receptor alternate reading frame protein (TARP) dendritic cell vaccine
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 15, 2022

Epithelial Ovarian Cancer, Ovarian Carcinoma Trial in Nijmegen (XP-DC vaccinations)

Not yet recruiting
  • Epithelial Ovarian Cancer
  • Ovarian Carcinoma
  • XP-DC vaccinations
  • Nijmegen, Gelderland, Netherlands
    Radboud University Medical Center
Mar 6, 2023

Diffuse Large-Cell Lymphoma, Primary Mediastinal Large B-Cell Lymphoma (PMBCL), Transformed Follicular Lymphoma (TFL) Trial in

Recruiting
  • Diffuse Large-Cell Lymphoma
  • +3 more
  • Pneumococcal conjugate vaccine (PCV13)
  • CD19 targeted CAR T Cell Therapy
  • Tampa, Florida
    Moffitt Cancer Center
May 31, 2022

'Corona-T-test' for Assessment of SARS-COV-2-specific T-cell

Completed
  • SARS-CoV-2 Infection
  • SARS-CoV-2 Vaccination
  • Corona-T-test
  • Moscow, Russian Federation
    National Research Center for Hematology
Dec 17, 2021

Prostatic Tumors, Prostate Cancer Trial run by the NCI (Autologus elutriated monocyte vaccine, Multi-epitope (ME) T-cell

Terminated
Has Results
  • Prostatic Neoplasms
  • Prostate Cancer
  • Autologus elutriated monocyte placebo vaccine
  • Multi-epitope (ME) T-cell receptor g alternate reading frame protein (TARP) vaccine
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 10, 2022

COVID-19 Vaccination in Multiple Sclerosis Patients Treated With

Completed
  • Multiple Sclerosis
  • +7 more
  • Elecsys semi-quantitative Anti-SARS-CoV-2 antibody test
  • T-Detect COVID T-cell blood test
  • Wellesley, Massachusetts
    Dragonfly Research, LLC
Jul 26, 2021

Head and Neck Squamous Cell Carcinoma, Breast Cancer, Sarcoma Trial in United States (Durvalumab, Tremelimumab, Poly ICLC)

Completed
  • Head and Neck Squamous Cell Carcinoma
  • +10 more
  • Atlanta, Georgia
  • +6 more
Mar 1, 2022

Diffuse Hemispheric Glioma, H3 G34-Mutant Trial in Los Angeles (biological, procedure, drug)

Not yet recruiting
  • Diffuse Hemispheric Glioma, H3 G34-Mutant
  • Dendritic Cell Tumor Peptide Vaccine
  • +6 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jul 13, 2022

Immune Responses to COVID-19 Vaccination in Lymphoma Patients

Active, not recruiting
  • Classical Hodgkin Lymphoma
  • +12 more
    • Bedford, Bedfordshire, United Kingdom
    • +8 more
    Feb 22, 2022

    Sickle Cell Disease, COVID-19 Vaccine, Vaccine Hesitancy Trial in Durham (SCD-specific COVID-19 vaccination information (SCVI)

    Not yet recruiting
    • Sickle Cell Disease
    • +2 more
    • SCD-specific COVID-19 vaccination information (SCVI) video
    • Durham, North Carolina
      Duke Adult Sickle Cell Program
    Aug 17, 2023

    Chronic Hepatitis B Trial in Hong Kong, Auckland (VRON-0200-AdC6, VRON-0200-AdC7)

    Recruiting
    • Chronic Hepatitis B
    • VRON-0200-AdC6
    • VRON-0200-AdC7
    • Hong Kong, Hong Kong
    • +1 more
    Oct 6, 2023

    Melanoma Trial in Philadelphia (Mature dendritic cell (DC) vaccine, Cyclophosphamide 300mg/m^2, Pembrolizumab)

    Active, not recruiting
    • Melanoma
    • Mature dendritic cell (DC) vaccine
    • +2 more
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Feb 2, 2023

    Granuloma, Aluminum Allergy Trial in Hellerup (Aluminum, Tetanus toxoid)

    Completed
    • Granuloma
    • Aluminum Allergy
    • Aluminum
    • Tetanus toxoid
    • Hellerup, Denmark
      National Allergy Research Centre, Gentofte Hospital
    Nov 8, 2023

    Esophageal Cancer, Pancreas Cancer, Ovarian Cancer Trial in Edegem (IL15-transpresenting WT1-targeted Dendritic Cell Vaccine)

    Not yet recruiting
    • Esophageal Cancer
    • +3 more
    • IL15-transpresenting WT1-targeted Dendritic Cell Vaccine
    • Edegem, Belgium
      Antwerp University Hospital
    Jul 19, 2023

    Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in

    Not yet recruiting
    • Systemic Sclerosis
    • SARS-CoV 2 Vaccination
      • (no location specified)
      Jul 24, 2023

      Metastatic NSCLC Trial in France (UCPVax)

      Active, not recruiting
      • Metastatic Non-small Cell Lung Cancer
      • Besancon, France
      • +4 more
      Sep 22, 2022

      Mumps, Measles, Rubella Trial in Zürich (MMR booster vaccination (as M-M-R-VaxPro))

      Not yet recruiting
      • Mumps
      • +2 more
      • MMR booster vaccination (as M-M-R-VaxPro)
      • Zürich, Switzerland
        Epidemiology, Biostatistics and Prevention Institute University
      Jun 8, 2023

      Follicular Lymphoma, Mantle Cell Lymphoma Trial in Rouen (Determination of COVID-19 vacciantion efficacy)

      Completed
      • Follicular Lymphoma
      • Mantle Cell Lymphoma
      • Determination of COVID-19 vacciantion efficacy
      • Rouen, France
        Centre Henri Becquerel
      Dec 22, 2022

      Melanoma Trial in Stockholm (Cyclophosphamide, Fludarabine, T cells)

      Recruiting
      • Melanoma
      • Stockholm, Sweden
        Karolinska University Hospital
      Sep 17, 2020

      COVID-19 Trial (Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) (WSK-V101C), Recombinant COVID-19

      Not yet recruiting
      • COVID-19
      • Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) (WSK-V101C)
      • Recombinant COVID-19 vaccine(Sf9 Cell) (WSK-V101)
      • (no location specified)
      Jun 19, 2023

      Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,

      Not yet recruiting
      • Acute Lymphoblastic Leukemia
      • +9 more
      • Allogeneic Hematopoietic Stem Cell Transplantation
      • +7 more
      • Duarte, California
      • +1 more
      Sep 22, 2023

      Extranodal NK T Cell Lymphoma, NK-Cell Leukemia Trial in Xuzhou (Anti-CD56 CAR T)

      Recruiting
      • Extranodal NK T Cell Lymphoma
      • NK-Cell Leukemia
      • Anti-CD56 CAR T
      • Xuzhou, Jiangsu, China
        The Affiliated Hospital of Xuzhou Medical University
      Jul 10, 2023

      T Lymphoblastic Leukemia/Lymphoma Trial in Hangzhou (Chidamide)

      Recruiting
      • T Lymphoblastic Leukemia/Lymphoma
      • Hangzhou, Zhejiang, China
        The First Hospital of Zhejiang Medical Colleage Zhejiang Univers
      Aug 7, 2023